Success stories 12 Dic 2023 "LA NOSTRA PRIMA SCELTA È STATA E SARÀ SEMPRE LA SVIZZERA" M&K Global AG è una holding con sede a Berna che si occupa di strategie per l’integrazione dei servizi con droni, implementazione nel mondo r...
News 26 Mar 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
Actualités 26 Mar 2024 Les Grands Titres de Suisse occidentale (Mars 2024) D’approches innovantes en matière de soins cardiaques et de plastiques durables à l’amélioration des thérapies pour les lésions de la moelle épin...
Novità 02 Giu 2023 Le ultime ricerche indicano che il 20% delle aziende biotecnologiche europee ha attualmente sede in Svizzera Press release Una nuova ricerca condotta da IQVIA e pubblicata recentemente nello Swiss Biotech Report 2023 mostra che il 20% delle aziende biotecnologiche eur...
News 15 Ago 2023 SAEKI Robotics secures investment of 2.3 million US dollars SAEKI Robotics has secured investment of 2.3 million US dollars as part of a seed funding round. The fresh capital will be put towards building a...
Headquarters 15 Giu 2023 Open Your HQ Are you a biopharmaceutical company seeking to access the European market? Switzerland could be the perfect location for your commercial headquar...
News 24 Mag 2023 Latest research shows 20% of European biotechs now headquartered in Switzerland Press release New research conducted by IQVIA and recently published in the 2023 Swiss Biotech Report shows that 20% of European biotech companies are now head...
Actualités 02 Giu 2023 UNE ÉTUDE RÉCENTE MONTRE QUE 20 % DES SOCIÉTÉS DE BIOTECHNOLOGIE EUROPÉENNES ONT DÉSORMAIS LEUR SIÈGE EN SUISSE Press release Une nouvelle étude menée par IQVIA et récemment publiée dans le Swiss Biotech Report 2023 montre que 20 % des sociétés de biotechnologie eur...
News 20 Feb 2023 Limula and CSEM collaborate to make cellular therapies more accessible To improve the accessibility of cellular therapies using automation, Limula has received support from the CSEM from the prototyping phase to the ...
News 26 Gen 2023 Bionomous secures USD 2.7 million to automate life science research Bionomous, a start-up based in the canton of Fribourg, raised USD 2.7 Million for its first CE-marked device which helps automate life science re...
Actualités 26 Gen 2023 Bionomous lève USD 2,7 millions pour automatiser la recherche en sciences de la vie Bionomous a levé USD 2,7 millions pour son premier dispositif marqué CE qui aide à automatiser les processus de recherche en sciences de la vie.
Press Release 15 Dic 2022 Swiss technology for digital worlds For the fifth time in a row, Switzerland is taking part in the Consumer Electronics Show (CES) in Las Vegas. Under the motto "swisstech for exten...
Communiqués de Presse 15 Dic 2022 Technologie suisse pour mondes numériques La Suisse participera au Consumer Electronics Show (CES) de Las Vegas pour la cinquième fois de son histoire, du 5 au 8 janvier 2023. Sous la dev...
News 05 Lug 2022 CHF 178 million to further develop life sciences in the canton of Vaud To consolidate the development of life sciences in the canton of Vaud, the State Council has announced an investment of CHF 178.71 million in the...
Actualités 05 Lug 2022 CHF 178 millions pour développer davantage les sciences de la vie dans le canton de Vaud Pour renforcer le développement des sciences de la vie dans le canton de Vaud, le Conseil d’État a annoncé un investissement de CHF 178,71 millio...
News 11 Mag 2022 Eurostars grants CEIDOS and Limula EUR 1.14 million for an innovative device In collaboration with Limula, Valais-based CEIDOS has received a grant of EUR 1.14 million from Eurostars to develop a platform dedicated to the ...